Master regulators of FGFR2 signalling and breast cancer risk

Michael N. C. Fletcher, Mauro A. A. Castro, Xin Wang, Ines De Santiago, Martin O'Reilly, Suet-Feung Chin, Oscar M. Rueda, Carlos Caldas, Bruce A. J. Ponder, Florian Markowetz, Kerstin B. Meyer

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

177 Citations (Scopus)
28 Downloads (CityUHK Scholars)

Abstract

The fibroblast growth factor receptor 2 (FGFR2) locus has been consistently identified as a breast cancer risk locus in independent genome-wide association studies. However, the molecular mechanisms underlying FGFR2-mediated risk are still unknown. Using model systems we show that FGFR2-regulated genes are preferentially linked to breast cancer risk loci in expression quantitative trait loci analysis, supporting the concept that risk genes cluster in pathways. Using a network derived from 2,000 transcriptional profiles we identify SPDEF, ERα, FOXA1, GATA3 and PTTG1 as master regulators of fibroblast growth factor receptor 2 signalling, and show that ERα occupancy responds to fibroblast growth factor receptor 2 signalling. Our results indicate that ERα, FOXA1 and GATA3 contribute to the regulation of breast cancer susceptibility genes, which is consistent with the effects of anti-oestrogen treatment in breast cancer prevention, and suggest that fibroblast growth factor receptor 2 signalling has an important role in mediating breast cancer risk. © 2013 Macmillan Publishers Limited. All rights reserved.
Original languageEnglish
Article number2464
JournalNature Communications
Volume4
DOIs
Publication statusPublished - 2013
Externally publishedYes

Publisher's Copyright Statement

  • This full text is made available under CC-BY-NC-SA 3.0. https://creativecommons.org/licenses/by-nc-sa/3.0/

Fingerprint

Dive into the research topics of 'Master regulators of FGFR2 signalling and breast cancer risk'. Together they form a unique fingerprint.

Cite this